Possible Role of Autophagy in the Treatment of Pancreatic Cancer with Histone Deacetylase Inhibitors
Pancreatic cancer is a lethal disease and notoriously difficult to treat. Only a small proportion is curative by surgical resection, whilst standard chemotherapy for patients with advanced disease has only a modest effect with substantial toxicity. Clearly there is a need for the continual developme...
Main Author: | Hidemi Rikiishi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2010-11-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/2/4/2026/ |
Similar Items
-
Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
by: Monica Phimmachanh, et al.
Published: (2020-10-01) -
Histone Deacetylases and their Inhibitors in Cancer Epigenetics
by: Kelly N. Hassell
Published: (2019-11-01) -
The Role of Dietary Histone Deacetylases (HDACs) Inhibitors in Health and Disease
by: Shalome A. Bassett, et al.
Published: (2014-10-01) -
Histone Deacetylase Inhibitors as Anticancer Drugs
by: Tomas Eckschlager, et al.
Published: (2017-07-01) -
Medicinal chemistry of histone deacetylase inhibitors
by: Ružić Dušan, et al.
Published: (2021-01-01)